A nationwide survey on the use of heated humidified high flow oxygen therapy on the paediatric wards in the UK: current practice and research priorities.
Adjunctive therapy
Children
High flow nasal cannula
Oxygen therapy
Paediatrics
Journal
BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804
Informations de publication
Date de publication:
06 03 2020
06 03 2020
Historique:
received:
06
12
2019
accepted:
25
02
2020
entrez:
7
3
2020
pubmed:
7
3
2020
medline:
25
2
2021
Statut:
epublish
Résumé
Heated Humidified High Flow Nasal Cannula Oxygen Therapy (HHFNC) is increasingly used on the paediatric wards and High Dependency Units (HDU) for different types of pathologies and different age groups. We aimed to describe current practice related to the use of HHFNC on the paediatric wards and HDUs, weaning practices and preferred outcome measures for future research. We carried out a cross-sectional online survey of UK paediatric consultants or their delegates working on the paediatric wards. Descriptive analysis of their geographical, and organizational characteristics, their specialties, and their level of experience was investigated. Reasons for HHFNC initiation, weaning criteria, patients' characteristics and their primary pathologies were also analysed. Participation of 218 paediatricians from 81 hospitals (Median: 2.7, Range: 1-11) was registered. HHFNC was provided in most of the surveyed hospitals (93%, 75/81). A High Dependency Unit (HDU) was available in 47 hospitals (58%); less than a third of those have a dedicated paediatrician. Decisions around HHFNC were made solely by paediatricians in (75%) of the cases, mostly at hospitals with no HDU compared to those with dedicated HDUs (70.3% VS 36.6, 95%CI:22.6-50.4%, P < .001). HHFNC was reported by nearly two-thirds (68%) of the practitioners who used it on the wards to be as effective or superior to CPAP (Continuous Positive Airway Pressure) with fewer complications. Failure rate while on HHFNC was identified as the most important outcome measure in any future research followed by the length of need for HHFNC support (37.1, and 28% respectively). This survey showed support for developing paediatric-specific national guidance on the use of HHFNC on the wards. Our list of defined research priorities may help guide further collaborative research efforts in this field.
Sections du résumé
BACKGROUND
Heated Humidified High Flow Nasal Cannula Oxygen Therapy (HHFNC) is increasingly used on the paediatric wards and High Dependency Units (HDU) for different types of pathologies and different age groups. We aimed to describe current practice related to the use of HHFNC on the paediatric wards and HDUs, weaning practices and preferred outcome measures for future research.
METHODS
We carried out a cross-sectional online survey of UK paediatric consultants or their delegates working on the paediatric wards. Descriptive analysis of their geographical, and organizational characteristics, their specialties, and their level of experience was investigated. Reasons for HHFNC initiation, weaning criteria, patients' characteristics and their primary pathologies were also analysed.
RESULTS
Participation of 218 paediatricians from 81 hospitals (Median: 2.7, Range: 1-11) was registered. HHFNC was provided in most of the surveyed hospitals (93%, 75/81). A High Dependency Unit (HDU) was available in 47 hospitals (58%); less than a third of those have a dedicated paediatrician. Decisions around HHFNC were made solely by paediatricians in (75%) of the cases, mostly at hospitals with no HDU compared to those with dedicated HDUs (70.3% VS 36.6, 95%CI:22.6-50.4%, P < .001). HHFNC was reported by nearly two-thirds (68%) of the practitioners who used it on the wards to be as effective or superior to CPAP (Continuous Positive Airway Pressure) with fewer complications. Failure rate while on HHFNC was identified as the most important outcome measure in any future research followed by the length of need for HHFNC support (37.1, and 28% respectively).
CONCLUSION
This survey showed support for developing paediatric-specific national guidance on the use of HHFNC on the wards. Our list of defined research priorities may help guide further collaborative research efforts in this field.
Identifiants
pubmed: 32138701
doi: 10.1186/s12887-020-1998-1
pii: 10.1186/s12887-020-1998-1
pmc: PMC7059285
doi:
Substances chimiques
Oxygen
S88TT14065
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
109Références
Matern Health Neonatol Perinatol. 2017 Sep 6;3:15
pubmed: 28904810
Respir Med. 2009 Oct;103(10):1400-5
pubmed: 19467849
Scand J Trauma Resusc Emerg Med. 2016 Jul 12;24:93
pubmed: 27405336
JAMA Pediatr. 2016 Aug 8;:
pubmed: 27532363
Acta Paediatr. 2013 Mar;102(3):249-53
pubmed: 23167445
J Pediatr. 2019 Dec;215:199-208.e8
pubmed: 31570155
J Paediatr Child Health. 2012 Jan;48(1):16-21
pubmed: 21988616
Interact Cardiovasc Thorac Surg. 2014 Sep;19(3):456-61
pubmed: 24912486
Arch Dis Child. 2015 Jun;100(6):571-5
pubmed: 25452315
Respir Care. 2017 Jun;62(6):662-677
pubmed: 28546371
Respir Care. 2013 Jan;58(1):98-122
pubmed: 23271822
Expert Rev Respir Med. 2017 Dec;11(12):945-953
pubmed: 28994337
Int J Prev Med. 2015 Apr 10;6:33
pubmed: 25949783
Emergencias. 2018 Dic;30(6):395-399
pubmed: 30638342
Arch Dis Child. 2017 Mar;102(3):296-297
pubmed: 28119404
Intensive Care Med. 2017 Jun;43(6):954-955
pubmed: 28364301
J Paediatr Child Health. 2012 Feb;48(2):106-13
pubmed: 21470336
Respir Care. 2019 Oct;64(10):1240-1249
pubmed: 31088986
Intensive Care Med. 2017 Feb;43(2):209-216
pubmed: 28124736
Lancet. 2015 Sep 12;386(9998):1057-65
pubmed: 26296950
Intensive Care Med. 2017 Feb;43(2):246-249
pubmed: 28124737
BMC Pediatr. 2017 Jan 17;17(1):20
pubmed: 28095826
Ann Intensive Care. 2014 Sep 30;4:29
pubmed: 25593745
Crit Care. 2018 Jun 4;22(1):144
pubmed: 29866165
J Pediatr (Rio J). 2017 Nov - Dec;93 Suppl 1:36-45
pubmed: 28818509
Pediatr Crit Care Med. 2017 Jul;18(7):e274-e280
pubmed: 28459761
Paediatr Child Health. 2018 Dec;23(8):555-556
pubmed: 31043841
J Crit Care. 2010 Sep;25(3):463-8
pubmed: 19781896